AC Immune Alzheimer's Drug Reduces Cognitive Decline but Misses Functional Endpoints | BioSpace
How AC Immune CEO Andrea Pfeifer plans to conquer dementia – European CEO
AC Immune (@AC_Immune_SA) / Twitter
AC Immune inks $1.7bn deal with Lilly, strategic partnership with WuXi
AC Immune (@AC_Immune_SA) / Twitter
Lilly teams up with AC Immune for Alzheimer's drug
AC Immune SA | Lausanne, Switzerland
AC Immune News, Reviews & Resources - Labiotech.eu
The Alzheimer's debate may not seem positive, but AC Immune's CEO promises it's been a breakthrough year | Fierce Biotech
Global Business Reports - Dr. Andrea Pfeifer
AC Immune and Lilly Announce License and Collaboration Agreement | Business Wire
AC Immune News, Reviews & Resources - Labiotech.eu
AC Immune claims a tau win in Alzheimer's | Evaluate
AC Immune acquires Parkinson's vaccine candidate
AC Immune: Old Theory, New Company (NASDAQ:ACIU) | Seeking Alpha
Could The AC Immune SA (NASDAQ:ACIU) Ownership Structure Tell Us Something Useful?
AC IMMUNE'S ROBUST PIPELINE | AC immune SA
AC Immune (@AC_Immune_SA) / Twitter
AC Immune SA | Precision medicine for neurodegenerative diseases
Ambassadeur de la Health Valley, AC Immune finalise sa levée au Nasdaq à 117,5 M$ | Republic of Innovation
AC Immune (@AC_Immune_SA) / Twitter
AC Immune picks up Phase 2-ready drug for Parkinson's in $58M deal with Affiris - MedCity News
AC Immune raises USD 43.5 million (CHF 42.7 million) in Financing Round E | Republic of Innovation
AC Immune Announces First Positive Cognitive Results for a
